Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database

American Journal of Human Genetics

Volumn 62, Issue 4, 1998, Pages 824-833

  Jeanpierre, C ^a,b   Denamur, E ^c   Henry, I ^a   Cabanis, M O ^a   Luce, S ^a   Cecille A ^c   Elion, J ^c   Peuchmaur, M ^c   Loirat, C ^c   Niaudet, P ^a,b   Gubler, M C ^a   Junien, C ^a  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENYS DRASH SYNDROME; DISEASE ASSOCIATION; EXON; FEMALE; GENE MUTATION; HUMAN; MALE; MUTATION RATE; NEPHROBLASTOMA; PRIORITY JOURNAL; PSEUDOHERMAPHRODITISM;

EID: 17344364993     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301806     Document Type: Article

References (42)

1. Akasaka Y, Kikuchi H, Nagai T, Hiraoka N, Kato S, Hata J (1993) A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS Lett 317:39-43
2. Baird PN, Santos A, Groves N, Jadresic L, Cowell JK (1992) Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1:301-305
3. Barbaux S, Niaudet P, Gubler M-C, Grünfeld J-P, Jaubert F, Kutten F, Nihoul Fékété C, et al (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467-470
4. Bardeesy N, Zabel B, Schmitt K, Pelletier J (1994) WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21:663-665
5. Baylin SB (1997) Tying all together: epigenetics, genetics, cell cycle and cancer. Science 277:1948-1949
6. Beaudet AL, Tsui LC (1993) A suggested nomenclature for designing mutations. Hum Mutat 2:245-248
7. Bickmore WA, Oghene K, Little MH, Seawhright A, Van Heyningen V, Hastie ND (1992) Modulation of DNA binding specificity by alternative splicing of the Wilms tumor WT1 gene transcript. Science 257:235-237
8. Coppes MJ, Campbell CE, Williams BRG (1993) The role of WT1 in Wilms tumorigenesis. FASEB J 7:886-895
9. Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BRG (1992) Inherited WT1 mutations in Denys-Drash syndrome. Cancer Res 52:6125-6128
10. Denys P, Malvaux P, Van den Berghe H, Tanghe W, Proesmans W (1967) Association d'un syndrome anatomopathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une néphropathie parenchymateuse et d'un mosaicisme XX/XY. Arch Fr Pediatr 24:729-739
11. Drash A, Sherman F, Hartmann W, Blizzard RM (1970) A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension and degenerative renal disease. J Pediatr 76: 585-593
12. Drummond IA, Madden S, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674-677
13. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher FJ III, Sukhatme VP (1994) DNA recognition by splicing variant of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14:3800-3809
14. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell R, Isselbacher KJ, Haber DA (1995) Truncated WT1 mutants alter the subnuclear localization of the wild type protein. Proc Natl Acad Sci USA 92:11960-11964
15. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622
16. Habib R, Gubler MC, Antignac C, Gagnadoux MF (1993) Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol Necker Hosp 22: 43-57
17. Huff V (1996) Genotype/phenotype correlations in Wilms' tumor. Med Pediatr Oncol 27:408-414
18. Huff V, Jaffe N, Saunders GF, Strong LC, Villalba F, Ruteshouser EC (1995) WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Am J Hum Genet 56:84-90
19. Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, et al (1990) Clinicopathologic review of twelve children with nephropathy, Wilms tumor and genital abnormalities. J Pediatr 117:717-725
20. Jeanpierre C, Béroud C, Niaudet P, Junien C (1998) Software and database for the analysis of mutations in the human WT1 gene. Nucleic Acids Res 26:271-274
21. Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve A, Niikawa N (1994) Mosaic and polymorphic imprinting of the WT1 gene in humans. Nat Genet 6:305-309
22. Kaplinsky C, Ghahremani M, Frisberg Y, Rechavi G, Pelletier J (1996) Familial Wilms' tumor associated with a WT1 zinc finger mutation. Genomics 38:451-453
23. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT1 is required for early kidney development. Cell 74:679-691
24. Larsson SH, Charlieu J-P, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, et al (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401
25. Little M, Holmes G, Bickmore W, Van Heyningen V, Hastie N, Wainwright B (1995) DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome point mutations. Hum Mol Genet 4:351-358
26. Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND (1992) Zinc finger mutations within the WT1 gene in Wilms' tumor patients. Proc Natl Acad Sci USA 89: 4791-4795
27. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209-225
28. Mitsuya K, Sui H, Meguro M, Kugoh H, Jinno Y, Niikawa N, Oshimura M (1997) Paternal expression of WT1 in human fibroblasts and lymphocytes. Hum Mol Genet 6: 2243-2246
29. Moffett P, Bruening W, Nakagama H, Bardeesy N, Housman D, Housman DE, Pelletier J (1995) Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA 92:11105-11109
30. Nordenskjöld A, Fricke G, Anvret M (1995a) Absence of mutations in the WT1 gene in patients with XY gonadal dysgenesis. Hum Genet 96:102-104
31. Nordenskjöld A, Friedman E, Sandstedt B, Söderhäll S, Anvret M (1995b) Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients. Int J Cancer 63: 516-522
32. Ogawa O, Eccles MR, Yun K, Mueller RF, Holdaway MDD, Reeve AE (1993) A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum Mol Genet 2:203-204
33. Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE (1991) WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431-434
34. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, et al (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-196
35. Renshaw J, King-Underwood L, Pritchard-Jones K (1997) Differential splicing of exon 5 of the Wilms tumour (WT1) gene. Genes Chromosom Cancer 19:256-266
36. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ III (1994) The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206
37. Schmitt K, Zabel B, Tulzer G, Eitelberger F, Pelletier J (1995) Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases? Eur J Pediatr 154:577-581
38. Schumacher V, Schneider S, Figgz A, Wildhardt G, Harms D, Schmidt D, Weirich A, et al (1997) Correlations of germline mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972-3977
39. Tadokoro K, Oki N, Sakai A, Fujii H, Ohshima A, Nagafuchi S, Inoue T, et al (1993) PCR detection of 9 polymorphisms in the WT1 gene. Hum Mol Genet 2:2205-2206
40. Wang Z-Y, Madden SL, Deuel TF, Rauscher FJ III (1992) The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002
41. Wang Z-Y, Qiu Q-Q, Deuel TF (1993) The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem 268:9172-9175
42. Wang Z-Y, Qiu Q-Q, Huang J, Gurrieri M, Deuel T (1995) Products of alternative spliced transcripts of the Wilms' tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415-422